Harnessing innovation to accelerate progress and end the HIV epidemic by 2030
Innovation in HIV care and prevention is transforming the fight, but there is more to be done in order to meet the UNAIDS targets of ending the HIV epidemic by 2030 ...
Gilead Sciences Inc. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Zacks.com on MSN13h
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Zacks.com on MSN14h
Wall Street Bulls Look Optimistic About Gilead (GILD): Should You Buy?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a ...
FiercePharma23h
Roche, Gilead top patient groups' rankings of pharma ESG practices
When asked about each segment of ESG, almost all of the surveyed groups, 94%, said that the impact a pharma has on society is ...